New drug extends multiple sclerosis options
563410
25/11/2004 - The first in a completely new class of drug for multiple sclerosis has been approved in the US, opening up a new avenue of treatment for sufferers of the debilitating diseases and potential blockbuster revenues for developers Elan and Biogen
344280
US researchers find two potential targets for treating multiple sclerosis after studying proteins in the brain.
610018
New technology could lead to safer, more effective drugs.
683607
AtheroGenics announces the path forward for its lead drug.
684253
NEW YORK  - An experimental drug has been  shown to combat the underlying cause of nerve damage that  occurs in people with diabetes.
93812
The results from the new clinical trial could increase the chances that the Food and Drug Administration will approve the drug for that use.
321841
The Food and Drug Administration yesterday approved a drug for multiple sclerosis that has shown early evidence of being more effective than existing drugs.
128455
MONDAY, Nov. 8 (HealthDayNews) -- Memory problems that prevent multiple sclerosis sufferers from doing their jobs are extremely troublesome and disheartening, say doctors, but a drug geared for Alzheimer's patients may offer some help.
271543
The Food and Drug Administration strongly endorsed Biogen Idec Inc.'s new multiple sclerosis treatment, putting the Cambridge firm in position to expand the market for MS drugs and win greater market share. The drug, formerly called Antegren but renamed Tysabri, was developed with Elan Pharmaceuticals of Ireland. The FDA approved Tysabri for use on its own and in ...
445553
Drugs given to patients with multiple  sclerosis can reduce brain tissue loss and slow down the  progression of the illness, scientists said on Friday.
747218
Women with advanced breast cancer that other treatments have failed to stop gained a new option Tuesday with the approval of a novel drug made by GlaxoSmithKline PLC.
371520
Biogen Idec Inc. won federal approval for its new anti-multiple sclerosis drug Antegren - the first new treatment for MS patients in eight years.
733890
NEW YORK, NOVEMBER 25: The Federal Government has just approved a new medicine for multiple sclerosis that doctors say represents a new treatment approach that will significantly reduce the frequency of disabling episodes.
287736
TORONTO - A new but potentially costly treatment for multiple sclerosis has received fast-track approval from the US Food and Drug Administration.
239484
Biogen Idec Inc. of Cambridge will ask a US advisory committee on July 31 to recommend expanding use of the multiple sclerosis drug, Tysabri, for patients with moderate to severe Crohn's disease. A Food and Drug Administration panel will discuss the risks and benefits of the treatment at a meeting in Gaithersburg, Md., according to a notice posted ...
320147
Cancer drug shows exceptional promise as it moves toward FDA review.
281372
Better test results for Elan Corp's key  Antegren drug lifted the Irish company's shares more than 10  percent as analysts said the data improved its chances of  becoming the leading multiple sclerosis treatment.